Urofacial syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Urofacial syndrome
Synonyms	Ochoa syndrome
Pronounce	N/A
Specialty	N/A
Symptoms	Urinary incontinence, urinary tract infection, facial paralysis
Complications	Kidney damage, hydronephrosis
Onset	Infancy or childhood
Duration	Lifelong
Types	N/A
Causes	Mutations in the HPSE2 or LRIG2 genes
Risks	Family history of the condition
Diagnosis	Genetic testing, clinical evaluation
Differential diagnosis	Vesicoureteral reflux, neurogenic bladder
Prevention	N/A
Treatment	Antibiotics for infections, surgical intervention for severe cases
Medication	N/A
Prognosis	Variable, depends on severity and management
Frequency	Rare
Deaths	N/A

A rare genetic disorder affecting the urinary and facial systems

Introduction

Urofacial syndrome, also known as Ochoa syndrome, is a rare genetic disorder characterized by abnormalities in the urinary and facial systems. It is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition.

Clinical Features

The primary features of urofacial syndrome include:

• Urinary tract abnormalities: Individuals with this syndrome often experience urinary incontinence, urinary tract infections, and vesicoureteral reflux, which is the backward flow of urine from the bladder into the kidneys.
• Facial abnormalities: Affected individuals may have a characteristic facial expression, often described as an "inverted smile" or "grimace" when attempting to smile.

Genetics

Urofacial syndrome is caused by mutations in specific genes that are involved in the development and function of the urinary and facial systems. The condition follows an autosomal recessive inheritance pattern, as illustrated in the diagram. This means that both parents of an affected individual are typically carriers of one copy of the mutated gene but do not show symptoms themselves.

Diagnosis

Diagnosis of urofacial syndrome is based on clinical evaluation, family history, and genetic testing. The presence of both urinary and facial abnormalities is key to suspecting this condition. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes.

Management

Management of urofacial syndrome involves addressing the urinary and facial symptoms. This may include:

• Urological interventions: To manage urinary tract infections and incontinence, medical and surgical options may be considered.
• Facial therapy: Physical therapy and, in some cases, surgical interventions may be used to address facial muscle function.

Prognosis

The prognosis for individuals with urofacial syndrome varies depending on the severity of the symptoms and the effectiveness of the management strategies. Early diagnosis and intervention can improve quality of life and reduce complications.

See also

• Genetic disorder
• Urinary tract infection
• Vesicoureteral reflux
• Autosomal recessive inheritance